Live Free or Die Legal
This website is not an official source of law. This website does not provide legal advice. For official legal materials, verify against the relevant court, legislature, agency, or other official source. Legal information may be incomplete, outdated, or incorrectly processed. Consult a qualified attorney for advice about a specific legal matter.

This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 329:52 · Definitions

Title
XXX: OCCUPATIONS AND PROFESSIONS
Chapter
329 · PHYSICIANS AND SURGEONS
Status
current
Official source linked
Yes
Official source Copy section link

329:52 Definitions. – In this subdivision:

Copy link
I.

"Abnormal development" means:

Copy link
(a)

"Gynecomastia" which is the abnormal development of breast tissue in biological males;

Copy link
(b)

"Macromastia" which is excessive development of breast tissue in biological females and includes juvenile hypertrophy of the breast and gigantomastia; or

Copy link
(c)

"Symptomatic macromastia" is macromastia which causes pain, deformity and/or recurrent skin infection.

Copy link
II.

"Breast surgery" includes:

Copy link
(a)

"Mammaplasty" which means surgery to reshape or resize the breasts by removing or transplanting tissue or inserting implants;

Copy link
(b)

"Mastectomy" which means surgery to remove all breast tissue; and/or

Copy link
(c)

"Mastopexy" which means surgery to lift the breast.

Copy link
III.

"Malignant" means cancerous or otherwise dangerous to the physical health of the person, including physiology compromised by infection, lack of blood flow, or physical injury.

Copy link
IV.

"Margin" means the healthy tissue removed around malignant tissue to ensure that all malignancy has been removed, and any additional tissue as recommended by relevant medical guidelines.

Copy link
V.

"Transgender chest surgery" means surgery to remove the breasts of a biological female through mastectomy or to increase the size of breasts of a biological male through augmentation mammaplasty, except in cases where such surgery is physiologically necessary, or is reconstructive in nature. In this paragraph, "physiologically necessary" refers to interventions, procedures, medications, or therapies essential for maintaining or restoring normal physiological function, preventing life-threatening conditions, or ensuring survival by addressing critical bodily needs, such as stabilizing vital systems, correcting severe imbalances, or supporting essential biological processes. Source. 2025, 287:1, eff. Sept. 30, 2025.

Copy link

Source note

Source. 2025, 287:1, eff. Sept. 30, 2025.

Source history

  • 2025, 287:1, eff. Sept. 30, 2025

Related materials

Bill relationships

  • 2026 HB1292 reference · effective 2027-01-01

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1292-FN reference · effective 2027-01-01

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1321 amend

    ravenous therapy. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Provision of Elective Intravenous Therapy. Amend RSA 329 by inserting after section 53 the following new subdivision: Provision of Elective Intravenous Therapy 329:54 Definitions. As used in this subdivision, "elective intravenous therapy" means a procedure: I. To admin

  • 2026 HB1335 amend · effective 2027-01-01

    use of Representatives in General Court convened: 1 New Subdivision; Physicians and Surgeons; Disclosure of Preferential Promotion Received by Provider; When Required. Amend RSA 329 by inserting after section 53 the following new subdivision: Disclosure of Preferential Promotion 329:54 Definitions. In this subdivision: (a) “Preferential promotion” means any financial arrangement, incentiv

  • 2026 HB1702 amend

    seeking chemical abortions that it may be possible to undo the effects of mifepristone, a drug commonly used to induce abortions. 2 New Subdivision; Chemical Abortion. Amend RSA 329 by inserting after section 53 the following new subdivision: Chemical Abortion 329:54 Definitions. In this subdivision: I. "Chemical abortion" or "medical abortion" means the use or prescription of any drug or

  • 2026 HB1702-FN amend

    seeking chemical abortions that it may be possible to undo the effects of mifepristone, a drug commonly used to induce abortions. 2 New Subdivision; Chemical Abortion. Amend RSA 329 by inserting after section 53 the following new subdivision: Chemical Abortion 329:54 Definitions. In this subdivision: I. "Chemical abortion" or "medical abortion" means the use or prescription of any drug or

  • 2026 HB1735 reference

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1735-FN reference

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1769 amend · effective 2027-01-01

    d medical facilities. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Public Funding and Abortion Referrals. Amend RSA 329 by inserting after section 50 the following new subdivision: Public Funding and Abortion Referrals 329:50-a Definitions. I. "Abortion" shall have the same meaning as provided in RSA 132:32, I. II. "Medical fa

  • 2026 HB1769-FN amend · effective 2027-01-01

    d medical facilities. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Public Funding and Abortion Referrals. Amend RSA 329 by inserting after section 50 the following new subdivision: Public Funding and Abortion Referrals 329:50-a Definitions. I. "Abortion" shall have the same meaning as provided in RSA 132:32, I. II. "Medical fa

  • 2026 HB1772 amend

    ct. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Section; Ibogaine; Administered Under FDA-approved Research Protocol. Amend RSA 329 by inserting after section RSA 329:1-h the following new section: 329:1-i Ibogaine; Administered Under FDA-approved Research Protocol. To the extent allowable by federal law, licensed physicians or qualified licensed

  • 2026 HB1772-FN-A amend

    ct. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Section; Ibogaine; Administered Under FDA-approved Research Protocol. Amend RSA 329 by inserting after section RSA 329:1-h the following new section: 329:1-i Ibogaine; Administered Under FDA-approved Research Protocol. To the extent allowable by federal law, licensed physicians or qualified licensed